Research Archives

Podcast 24 May 2024

How biotech is tackling myasthenia gravis

To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.

May 24, 2024

Expert Advice 26 Apr 2024

Biotech career: What it’s really like being a research assistant

Labiotech spoke to Elina Kuznecova, a research assistant at the University of Oxford, to find out about what the role of a research assistant entails.

April 26, 2024 - 6 minutesmins - By Roohi Mariam Peter

Best in Biotech 22 Mar 2024

6 biotechnology universities in the UK leading the way for future talent

Discover the pinnacle of biotechnology education in the UK with our article to the top universities offering cutting-edge programs.

March 22, 2024 - 10 minutesmins - By Willow Shah-Neville

Best in Biotech 8 Mar 2024

Eight biotechnology universities in Germany cultivating future leaders

Explore Germany’s top biotechnology universities! Uncover where tomorrow’s leaders are trained, bridging science with market success.

March 8, 2024 - 12 minutesmins - By Jules Adam

Protein inhibitors: cracking the code of disease mechanisms

Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.

February 27, 2024 - 4 minutesmins - By Ute Boronowsky

In Depth 26 Jan 2024

Long COVID: are we on the verge of a breakthrough?

Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities.

January 26, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 12 Jan 2024

AI and a brain organoid: can this combo take on supercomputers?

Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer.

January 12, 2024 - 5 minutesmins - By Roohi Mariam Peter

Best in Biotech 11 Jan 2024

Ten NK cell therapy companies to look out for this year

As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for.

January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Weekly Roundup 8 Dec 2023

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

December 8, 2023 - 14 minutesmins - By Willow Shah-Neville

News and Trends 1 Dec 2023

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising In the news this week, biotech Arvinas raises $350 million PIPE American protein degradation company Arvinas has bagged $350 million in a private placement (PIPE). The […]

December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. Viva Biotech closes $210 million funding round Chinese company Viva Biotech closed a funding round worth $210 […]

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Research

How biotech is tackling myasthenia gravis

Biotech career: What it’s really like being a research assistant

6 biotechnology universities in the UK leading the way for future talent

Eight biotechnology universities in Germany cultivating future leaders

Protein inhibitors: cracking the code of disease mechanisms

Long COVID: are we on the verge of a breakthrough?

AI and a brain organoid: can this combo take on supercomputers?

Ten NK cell therapy companies to look out for this year

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!